View in EDS

Using CRISPR-Cas9 to Dissect Cancer Mutations in Cell Lines.

Saved in:
Bibliographic Details
Title: Using CRISPR-Cas9 to Dissect Cancer Mutations in Cell Lines.
Authors: Sayed S; Medical Faculty and University Hospital Carl Gustav Carus, UCC Section Medical Systems Biology, TU Dresden, Dresden, Germany., Sürün D; Medical Faculty and University Hospital Carl Gustav Carus, UCC Section Medical Systems Biology, TU Dresden, Dresden, Germany., Mircetic J; Medical Faculty and University Hospital Carl Gustav Carus, UCC Section Medical Systems Biology, TU Dresden, Dresden, Germany., Sidorova OA; Medical Faculty and University Hospital Carl Gustav Carus, UCC Section Medical Systems Biology, TU Dresden, Dresden, Germany., Buchholz F; Medical Faculty and University Hospital Carl Gustav Carus, UCC Section Medical Systems Biology, TU Dresden, Dresden, Germany. frank.buchholz@tu-dresden.de.; National Center for Tumor Diseases (NCT) Dresden and German Cancer Research Center (DKFZ), Dresden, Germany. frank.buchholz@tu-dresden.de.; German Cancer Consortium (DKTK), Dresden, Germany. frank.buchholz@tu-dresden.de.
Source: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2022; Vol. 2508, pp. 235-260.
Publication Type: Journal Article
Journal Info: Publisher: Humana Press Country of Publication: United States NLM ID: 9214969 Publication Model: Print Cited Medium: Internet ISSN: 1940-6029 (Electronic) Linking ISSN: 10643745 NLM ISO Abbreviation: Methods Mol Biol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1940-6029
DOI:10.1007/978-1-0716-2376-3_18